BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Birnie E, Biemond JJ, Appelman B, de Bree GJ, Jonges M, Welkers MRA, Wiersinga WJ. Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant. JAMA 2022. [PMID: 35913747 DOI: 10.1001/jama.2022.13854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Owen A, Diaz JV, Guyatt G, Lamontagne F, Stegemann M, Vandvik PO, Agoritsas T. WHO Living Guidelines on antivirals for COVID-19 are evidence-based. Lancet 2022;400:2196-8. [PMID: 36372074 DOI: 10.1016/S0140-6736(22)02306-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Akinosoglou K, Rigopoulos EA, Kaiafa G, Daios S, Karlafti E, Ztriva E, Polychronopoulos G, Gogos C, Savopoulos C. Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience. Viruses 2022;15. [PMID: 36680160 DOI: 10.3390/v15010118] [Reference Citation Analysis]
3 Levine AC, Fukuta Y, Huaman MA, Ou J, Meisenberg BR, Patel B, Paxton JH, Hanley DF, Rijnders BJ, Gharbharan A, Rokx C, Zwaginga JJ, Alemany A, Mitjà O, Ouchi D, Millat-Martinez P, Durkalski-Mauldin V, Korley FK, Dumont LJ, Callaway CW, Libster R, Marc GP, Wappner D, Esteban I, Polack F, Sullivan DJ. COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials. medRxiv 2022:2022. [PMID: 36561181 DOI: 10.1101/2022.12.16.22283585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Capraru ID, Romanescu M, Anghel FM, Oancea C, Marian C, Sirbu IO, Chis AR, Ciordas PD. Identification of Genomic Variants of SARS-CoV-2 Using Nanopore Sequencing. Medicina (Kaunas) 2022;58. [PMID: 36557043 DOI: 10.3390/medicina58121841] [Reference Citation Analysis]
5 Guerra D, Beaumont T, RadiÄ L, Kerster G, van der Straten K, Yuan M, Torres JL, Lee WH, Liu H, Poniman M, Bontjer I, Burger JA, Claireaux M, Caniels TG, Snitselaar JL, Bijl TPL, Kruijer S, Ozorowski G, Gideonse D, Sliepen K, Ward AB, Eggink D, de Bree GJ, Wilson IA, Sanders RW, van Gils MJ. Broad SARS-CoV-2 Neutralization by Monoclonal and Bispecific Antibodies Derived from a Gamma-infected Individual. bioRxiv 2022:2022. [PMID: 36263063 DOI: 10.1101/2022.10.14.512216] [Reference Citation Analysis]
6 Gupta A, Konnova A, Smet M, Berkell M, Savoldi A, Morra M, Van averbeke V, De Winter F, Peserico D, Danese E, Hotterbeekx A, Righi E, De Nardo P, Tacconelli E, Kumar SM, Singh SK, mAb ORCHESTRA working group. Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments.. [DOI: 10.1101/2022.09.20.22280135] [Reference Citation Analysis]